Entrepreneur Greg Lindberg Publishes Audio Version of Latest Groundbreaking Book on Anti-Aging, Longevity and Leadership
May 08, 2024 13:48 ET
|
Lifelong Labs
Greg Lindberg Releases Audio Version of his Book Lifelong
AB Science:
May 07, 2024 12:05 ET
|
AB Science
COMMUNIQUE DE PRESSE UNE NOUVELLE PUBLICATION DANS LA REVUE MÉDICALE MUSCLE & NERVE VALIDE L’UTILISATION DU DECLIN DU SCORE ALSFRS-R (ΔFS) POUR LE DESIGN DES ETUDES CLINIQUES ET LE CHOIX DE...
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
May 07, 2024 12:05 ET
|
AB Science
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE...
Press Release - Rinf.tech: Translating IoT promises into tangible gains
May 07, 2024 09:40 ET
|
rinf.tech
BUCHAREST, Romania, May 07, 2024 (GLOBE NEWSWIRE) -- The Internet of Things (IoT) technology is becoming increasingly attractive and accessible for businesses. The growing interest in IoT...
AB Science : La Cour d’Appel de Paris confirme la mise hors de cause du Président Directeur Général d’AB Science, Alain Moussy, et diminue le montant de la sanction imposée à AB Science
May 02, 2024 13:14 ET
|
AB Science
COMMUNIQUE DE PRESSE LA COUR D’APPEL DE PARIS CONFIRME LA MISE HORS DE CAUSE DU PRESIDENT DIRECTEUR GENERAL D’AB SCIENCE, ALAIN MOUSSY, ET DIMINUE LE MONTANT DE LA SANCTION IMPOSEE...
AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science
May 02, 2024 13:14 ET
|
AB Science
PRESS RELEASE THE PARIS COURT OF APPEAL CONFIRMS THE ACQUITTAL OF THE CEO OF AB SCIENCE, ALAIN MOUSSY, AND REDUCES THE AMOUNT OF THE FINANCIAL PENALTY IMPOSED ON AB SCIENCE Paris, May 2, 2024, 7pm...
AB Science annonce un léger décalage de la publication de son rapport financier annuel 2023
April 30, 2024 12:56 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE UN LEGER DECALAGE DE LA PUBLICATION DE SON RAPPORT FINANCIER ANNUEL 2023 LA SOCIETE PUBLIERA SON RAPPORT FINANCIER ANNUEL 2023 AU PLUS TARD LE 15 MAI 2024 ...
AB Science announces a slight delay in the publication of its 2023 annual financial report
April 30, 2024 12:56 ET
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2023 ANNUAL FINANCIAL REPORT THE COMPANY WILL PUBLISH ITS 2023 ANNUAL FINANCIAL REPORT NO LATER THAN 15 MAY 2024 Paris,...
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
April 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 25, 2024 (GLOBE NEWSWIRE) -- Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche,...
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
April 15, 2024 08:00 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference